ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Grants Up Fourfold Since 1970; Rappaport, Jensen Speakers At Annual AACR,ASCO Meeting

April 25, 1975

President to Propose 2 Percent Increase in NIH Budge, Slowing Funding Growth

January 15, 1999

NCI Faced Pressure From Congress, HHS, White On Mammography Statement

April 11, 1997

NCI Is Convinced It Has Isolated Human Cancer Virus

February 14, 1975

US Oncology To Participate In Firm’s Ovarian Cancer Trial.

January 26, 2001

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002